UK: Mobile ‘phone litigation – don’t hang up just yet …

Last Updated: 27 November 2002
Article by Peter Wood

Vodafone, the world’s biggest mobile telephone operator, is being sued in the US for allegedly causing brain cancer to users of its mobile telephone network. In July this year, for the first time, Vodafone formally disclosed to its shareholders in its annual report the existence of the early stage litigation against it, adding:

"The company is not aware that the health risks alleged in such personal injury claims have been substantiated and will be vigorously defending such claims".

If upheld, the potential exposures to these claims are thought to run into US $ Bns. Vodafone is no stranger to such claims. Class actions in the US were filed in 2001 against a company in which Vodafone owns a 45% stake. However, this time though, Vodafone is actually named as one of a group of five defendants, which consist of mobile telephone operators, equipment suppliers and handset manufacturers. Each of the 4 claimants seeks US $1M in punitive damages, as well as compensatory and other awards.

The latest action in which Vodafone is named comes after almost a decade of lawsuits against the mobile telephone industry of allegations of links to brain cancer, in which mobile telephone carriers and equipment manufacturers have yet to lose a case. However, neurologist Chris Newman, who is suffering from a brain tumour, now claims there is evidence of sufficient quality to show a causal link between mobile telephones and his condition. Attorney, Peter Angelos, who made his name by successfully pursuing product liability litigation against the tobacco industry, represents him.

A preliminary evidential hearing held in March in the US District Court of Baltimore, marked the first time a US court had analysed whether the accumulated scientific evidence was rigorous enough to be considered at trial and, if so, to determine which of it, if any, should be allowed at any subsequent trial. Judge Blake was persuaded by Angelos to allow the lawsuit, totalling US $800 M, to proceed to trial, the outcome of which will be eagerly anticipated by the mobile communications industry on both sides of the Atlantic.

Despite the assurances contained in its annual report, the share price of Vodafone, which has become a leading global player in mobile telephones after acquiring a string of rival operators, was hit by new research published in June suggesting that radio frequency (RF) fields generated by mobile telephones could harm the brain. Although one expert involved in the litigation is quoted as saying, "It is as much a legal question as it is a scientific question", clearly the science will play a big part in the outcome.

To date, the most comprehensive British study, led by Sir William Stewart and published in 2001, concluded there was no evidence of a risk to health from mobile telephone use and was unable to find any link to increased risk of brain cancer. However, it also recommended more investigation was needed and consequently in January 2002 a new £7.4 M research programme was announced, backed by the Government and the mobile telephone industry. Further, the WHO is also looking at the possible effects on health of mobile telephones; of which it projects there will be 1.6 Bn worldwide users by 2005. The WHO notes "None of the recent reviews have concluded that exposure to RF fields from mobile telephones or their base stations causes any adverse health consequences."

Less comforting to mobile telephone network operators and manufacturers are the conclusions of the latest study to be published, a 2-year investigation conducted in Finland, home of the mobile telephone giant Nokia. It suggests that RF fields from mobile telephone handsets may affect the underlying physiology of the brain as cells taken from human blood vessels and grown in the laboratory behave abnormally when subjected to RF emissions. The effects remain even when RF levels are below the guidelines laid down by the European Commission (set using "dummy heads" to measure absorption). In particular, effects were seen in endothelial cells, which form the crucial "blood-brain barrier", which has evolved to shield the brain from potentially harmful substances. The Finnish study identified RF-induced changes in about 400 proteins inside these cells. One is a so-called "stress protein", namely HSB27, which is known to be involved in regulating blood-brain barrier permeability. Critics of the study maintain that the findings are not strong enough to cast serious doubt on the safety of mobile telephones. They say the study may have identified an in vitro physiological change, but provides no evidence of adverse health effects caused by it.

While the outcome of the US litigation is keenly anticipated, at least one US law firm has said it is considering filing in the federal court in Washington a "public interest lawsuit", the aim of which would be to attempt to force the US Government to regulate the mobile telephone industry.

The content of this article does not constitute legal advice and should not be relied on in that way. Specific advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions